VRNA Dividend: Verona Pharma PLC Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

VRNA Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	221	42	0	0	40	0
Revenue Growth (YoY)	--	--	--	-100%	--	--
Cost of Revenue	10	2	0	0	--	--
Gross Profit	210	39	0	0	--	--
Selling, General & Admin	221	149	50	26	33	29
Research & Development	45	44	17	49	79	44
Operating Expenses	266	194	67	75	113	74
Other Non Operating Income (Expenses)	2	3	1	9	15	8
Pretax Income	-72	-163	-53	-68	-55	-65
Income Tax Expense	8	10	0	0	0	0
Net Income	-81	-173	-54	-68	-55	-65
Net Income Growth	-35%	220%	-21%	24%	-15%	63%
Shares Outstanding (Diluted)	727.22	652.31	634.14	529.07	473.19	260.58
Shares Change (YoY)	12%	3%	20%	12%	82%	151%
EPS (Diluted)	-0.12	-0.26	-0.08	-0.13	-0.12	-0.25
EPS Growth	-36%	210%	-34%	8%	-52%	-36%
Free Cash Flow	-73	-122	-50	-59	-33	-45
Free Cash Flow Per Share	-0.1	-0.18	-0.07	-0.11	-0.06	-0.17
Gross Margin	95.02%	92.85%	0%	0%	--	--
Operating Margin	-25.33%	-366.66%	0%	0%	-182.5%	0%
Profit Margin	-36.65%	-411.9%	0%	0%	-137.5%	0%
Free Cash Flow Margin	-33.03%	-290.47%	0%	0%	-82.5%	0%
EBITDA	-55	-153	-67	-75	-73	-74
EBITDA Margin	-24.88%	-364.28%	0%	0%	-182.5%	0%
D&A For EBITDA	1	1	0	0	0	0
EBIT	-56	-154	-67	-75	-73	-74
EBIT Margin	-25.33%	-366.66%	0%	0%	-182.5%	0%
Effective Tax Rate	-11.11%	-6.13%	0%	0%	0%	0%